nodes	percent_of_prediction	percent_of_DWPC	metapath
Estazolam—CYP3A4—breast cancer	0.191	1	CbGaD
Estazolam—CYP3A4—Exemestane—breast cancer	0.0453	0.133	CbGbCtD
Estazolam—CYP3A4—Letrozole—breast cancer	0.0386	0.113	CbGbCtD
Estazolam—CYP3A4—Anastrozole—breast cancer	0.0344	0.101	CbGbCtD
Estazolam—CYP3A4—Toremifene—breast cancer	0.0314	0.0921	CbGbCtD
Estazolam—CYP3A4—Fulvestrant—breast cancer	0.0292	0.0856	CbGbCtD
Estazolam—CYP3A4—Thiotepa—breast cancer	0.026	0.0763	CbGbCtD
Estazolam—CYP3A4—Ixabepilone—breast cancer	0.0238	0.0698	CbGbCtD
Estazolam—CYP3A4—Lapatinib—breast cancer	0.0229	0.0672	CbGbCtD
Estazolam—CYP3A4—Raloxifene—breast cancer	0.0174	0.0509	CbGbCtD
Estazolam—CYP3A4—Vinorelbine—breast cancer	0.0127	0.0373	CbGbCtD
Estazolam—CYP3A4—Tamoxifen—breast cancer	0.0115	0.0336	CbGbCtD
Estazolam—CYP3A4—Mitoxantrone—breast cancer	0.0112	0.0328	CbGbCtD
Estazolam—CYP3A4—Paclitaxel—breast cancer	0.00894	0.0262	CbGbCtD
Estazolam—CYP3A4—Irinotecan—breast cancer	0.00882	0.0258	CbGbCtD
Estazolam—CYP3A4—Vinblastine—breast cancer	0.00784	0.023	CbGbCtD
Estazolam—CYP3A4—Docetaxel—breast cancer	0.00646	0.0189	CbGbCtD
Estazolam—CYP3A4—Doxorubicin—breast cancer	0.00482	0.0141	CbGbCtD
Estazolam—GABRP—mammary gland—breast cancer	0.000958	0.0882	CbGeAlD
Estazolam—Clonazepam—NAT2—breast cancer	0.000884	0.196	CrCbGaD
Estazolam—GABRP—nipple—breast cancer	0.000792	0.0729	CbGeAlD
Estazolam—GABRE—mammary gland—breast cancer	0.000731	0.0673	CbGeAlD
Estazolam—GABRG3—pituitary gland—breast cancer	0.000625	0.0575	CbGeAlD
Estazolam—GABRE—nipple—breast cancer	0.000605	0.0557	CbGeAlD
Estazolam—GABRB1—pituitary gland—breast cancer	0.000483	0.0445	CbGeAlD
Estazolam—GABRP—endometrium—breast cancer	0.000478	0.044	CbGeAlD
Estazolam—GABRP—uterus—breast cancer	0.000441	0.0406	CbGeAlD
Estazolam—GABRP—pituitary gland—breast cancer	0.000433	0.0398	CbGeAlD
Estazolam—GABRP—female reproductive system—breast cancer	0.000396	0.0365	CbGeAlD
Estazolam—GABRE—endometrium—breast cancer	0.000365	0.0336	CbGeAlD
Estazolam—GABRG2—pituitary gland—breast cancer	0.000365	0.0336	CbGeAlD
Estazolam—GABRA3—endocrine gland—breast cancer	0.000347	0.0319	CbGeAlD
Estazolam—GABRA2—adipose tissue—breast cancer	0.000332	0.0305	CbGeAlD
Estazolam—GABRR2—lymph node—breast cancer	0.000331	0.0305	CbGeAlD
Estazolam—GABRE—pituitary gland—breast cancer	0.00033	0.0304	CbGeAlD
Estazolam—GABRE—adipose tissue—breast cancer	0.000329	0.0303	CbGeAlD
Estazolam—GABRE—female reproductive system—breast cancer	0.000302	0.0278	CbGeAlD
Estazolam—GABRA2—adrenal gland—breast cancer	0.000298	0.0274	CbGeAlD
Estazolam—GABRE—adrenal gland—breast cancer	0.000295	0.0272	CbGeAlD
Estazolam—GABRB3—pituitary gland—breast cancer	0.00028	0.0258	CbGeAlD
Estazolam—GABRE—female gonad—breast cancer	0.000275	0.0253	CbGeAlD
Estazolam—GABRB3—female reproductive system—breast cancer	0.000256	0.0236	CbGeAlD
Estazolam—GABRB3—endocrine gland—breast cancer	0.000217	0.02	CbGeAlD
Estazolam—Ketazolam—CYP3A4—breast cancer	0.000199	0.0441	CrCbGaD
Estazolam—Chlordiazepoxide—CYP2D6—breast cancer	0.000193	0.0429	CrCbGaD
Estazolam—GABRA2—lymph node—breast cancer	0.000178	0.0164	CbGeAlD
Estazolam—GABRE—lymph node—breast cancer	0.000177	0.0163	CbGeAlD
Estazolam—Ketazolam—ALB—breast cancer	0.000173	0.0384	CrCbGaD
Estazolam—Chlordiazepoxide—CYP3A4—breast cancer	0.000166	0.0368	CrCbGaD
Estazolam—Ketazolam—ABCB1—breast cancer	0.000165	0.0367	CrCbGaD
Estazolam—Clonazepam—CYP3A4—breast cancer	0.00016	0.0355	CrCbGaD
Estazolam—Clorazepate—CYP3A4—breast cancer	0.000155	0.0344	CrCbGaD
Estazolam—Amoxapine—CYP2D6—breast cancer	0.000144	0.0319	CrCbGaD
Estazolam—Clobazam—CYP3A4—breast cancer	0.00014	0.0311	CrCbGaD
Estazolam—Alprazolam—CYP3A4—breast cancer	0.00014	0.0311	CrCbGaD
Estazolam—Diazepam—PTGS1—breast cancer	0.00014	0.0311	CrCbGaD
Estazolam—Clonazepam—ALB—breast cancer	0.00014	0.031	CrCbGaD
Estazolam—Quazepam—CYP3A4—breast cancer	0.000136	0.0302	CrCbGaD
Estazolam—CYP3A4—female reproductive system—breast cancer	0.000131	0.0121	CbGeAlD
Estazolam—Flunitrazepam—CYP3A4—breast cancer	0.000129	0.0285	CrCbGaD
Estazolam—Photosensitivity reaction—Doxorubicin—breast cancer	0.00012	0.000306	CcSEcCtD
Estazolam—Oedema—Docetaxel—breast cancer	0.00012	0.000306	CcSEcCtD
Estazolam—Weight increased—Doxorubicin—breast cancer	0.00012	0.000305	CcSEcCtD
Estazolam—Discomfort—Capecitabine—breast cancer	0.00012	0.000305	CcSEcCtD
Estazolam—Epistaxis—Epirubicin—breast cancer	0.00012	0.000305	CcSEcCtD
Estazolam—Pruritus—Gemcitabine—breast cancer	0.00012	0.000305	CcSEcCtD
Estazolam—Nausea—Thiotepa—breast cancer	0.000119	0.000304	CcSEcCtD
Estazolam—Weight decreased—Doxorubicin—breast cancer	0.000119	0.000304	CcSEcCtD
Estazolam—Sinusitis—Epirubicin—breast cancer	0.000119	0.000303	CcSEcCtD
Estazolam—Dry mouth—Capecitabine—breast cancer	0.000119	0.000302	CcSEcCtD
Estazolam—Agranulocytosis—Epirubicin—breast cancer	0.000118	0.000302	CcSEcCtD
Estazolam—Shock—Docetaxel—breast cancer	0.000118	0.000301	CcSEcCtD
Estazolam—Pruritus—Fluorouracil—breast cancer	0.000118	0.0003	CcSEcCtD
Estazolam—Visual impairment—Methotrexate—breast cancer	0.000117	0.000299	CcSEcCtD
Estazolam—Confusional state—Capecitabine—breast cancer	0.000117	0.000298	CcSEcCtD
Estazolam—Clobazam—ABCB1—breast cancer	0.000117	0.0259	CrCbGaD
Estazolam—Feeling abnormal—Paclitaxel—breast cancer	0.000117	0.000297	CcSEcCtD
Estazolam—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000116	0.000297	CcSEcCtD
Estazolam—Oedema—Capecitabine—breast cancer	0.000116	0.000296	CcSEcCtD
Estazolam—Nitrazepam—CYP3A4—breast cancer	0.000116	0.0257	CrCbGaD
Estazolam—Gastrointestinal pain—Paclitaxel—breast cancer	0.000116	0.000295	CcSEcCtD
Estazolam—Erythema multiforme—Methotrexate—breast cancer	0.000115	0.000293	CcSEcCtD
Estazolam—Neuropathy peripheral—Doxorubicin—breast cancer	0.000115	0.000293	CcSEcCtD
Estazolam—Dizziness—Irinotecan—breast cancer	0.000115	0.000292	CcSEcCtD
Estazolam—Adinazolam—CYP3A4—breast cancer	0.000114	0.0254	CrCbGaD
Estazolam—Shock—Capecitabine—breast cancer	0.000114	0.000291	CcSEcCtD
Estazolam—Rhinitis—Epirubicin—breast cancer	0.000114	0.000291	CcSEcCtD
Estazolam—Tinnitus—Methotrexate—breast cancer	0.000113	0.000289	CcSEcCtD
Estazolam—Pharyngitis—Epirubicin—breast cancer	0.000113	0.000288	CcSEcCtD
Estazolam—Sweating—Doxorubicin—breast cancer	0.000113	0.000287	CcSEcCtD
Estazolam—Urticaria—Paclitaxel—breast cancer	0.000112	0.000287	CcSEcCtD
Estazolam—Hyperhidrosis—Capecitabine—breast cancer	0.000112	0.000286	CcSEcCtD
Estazolam—Haematuria—Doxorubicin—breast cancer	0.000112	0.000285	CcSEcCtD
Estazolam—Abdominal pain—Paclitaxel—breast cancer	0.000112	0.000285	CcSEcCtD
Estazolam—Body temperature increased—Paclitaxel—breast cancer	0.000112	0.000285	CcSEcCtD
Estazolam—CYP3A4—endocrine gland—breast cancer	0.000111	0.0102	CbGeAlD
Estazolam—Epistaxis—Doxorubicin—breast cancer	0.000111	0.000282	CcSEcCtD
Estazolam—Prazepam—CYP3A4—breast cancer	0.000111	0.0245	CrCbGaD
Estazolam—Vomiting—Irinotecan—breast cancer	0.00011	0.000281	CcSEcCtD
Estazolam—Vomiting—Mitoxantrone—breast cancer	0.00011	0.000281	CcSEcCtD
Estazolam—Sinusitis—Doxorubicin—breast cancer	0.00011	0.000281	CcSEcCtD
Estazolam—Dizziness—Fluorouracil—breast cancer	0.00011	0.00028	CcSEcCtD
Estazolam—Visual impairment—Epirubicin—breast cancer	0.00011	0.00028	CcSEcCtD
Estazolam—Agranulocytosis—Doxorubicin—breast cancer	0.00011	0.000279	CcSEcCtD
Estazolam—Rash—Irinotecan—breast cancer	0.000109	0.000279	CcSEcCtD
Estazolam—Rash—Mitoxantrone—breast cancer	0.000109	0.000279	CcSEcCtD
Estazolam—Dermatitis—Irinotecan—breast cancer	0.000109	0.000279	CcSEcCtD
Estazolam—Dermatitis—Mitoxantrone—breast cancer	0.000109	0.000279	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000109	0.000279	CcSEcCtD
Estazolam—Chills—Methotrexate—breast cancer	0.000109	0.000278	CcSEcCtD
Estazolam—Headache—Mitoxantrone—breast cancer	0.000109	0.000277	CcSEcCtD
Estazolam—Headache—Irinotecan—breast cancer	0.000109	0.000277	CcSEcCtD
Estazolam—Paraesthesia—Docetaxel—breast cancer	0.000108	0.000275	CcSEcCtD
Estazolam—Erythema multiforme—Epirubicin—breast cancer	0.000108	0.000274	CcSEcCtD
Estazolam—Vomiting—Gemcitabine—breast cancer	0.000108	0.000274	CcSEcCtD
Estazolam—Dyspnoea—Docetaxel—breast cancer	0.000107	0.000273	CcSEcCtD
Estazolam—Somnolence—Docetaxel—breast cancer	0.000107	0.000272	CcSEcCtD
Estazolam—Rash—Gemcitabine—breast cancer	0.000107	0.000272	CcSEcCtD
Estazolam—Dermatitis—Gemcitabine—breast cancer	0.000107	0.000271	CcSEcCtD
Estazolam—Tinnitus—Epirubicin—breast cancer	0.000106	0.000271	CcSEcCtD
Estazolam—Malnutrition—Methotrexate—breast cancer	0.000106	0.00027	CcSEcCtD
Estazolam—Headache—Gemcitabine—breast cancer	0.000106	0.00027	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000106	0.00027	CcSEcCtD
Estazolam—Flushing—Epirubicin—breast cancer	0.000106	0.000269	CcSEcCtD
Estazolam—Vomiting—Fluorouracil—breast cancer	0.000106	0.000269	CcSEcCtD
Estazolam—Rhinitis—Doxorubicin—breast cancer	0.000106	0.000269	CcSEcCtD
Estazolam—Dyspepsia—Docetaxel—breast cancer	0.000106	0.000269	CcSEcCtD
Estazolam—Rash—Fluorouracil—breast cancer	0.000105	0.000267	CcSEcCtD
Estazolam—Dermatitis—Fluorouracil—breast cancer	0.000105	0.000267	CcSEcCtD
Estazolam—Pharyngitis—Doxorubicin—breast cancer	0.000105	0.000267	CcSEcCtD
Estazolam—Paraesthesia—Capecitabine—breast cancer	0.000104	0.000266	CcSEcCtD
Estazolam—Decreased appetite—Docetaxel—breast cancer	0.000104	0.000266	CcSEcCtD
Estazolam—Hypersensitivity—Paclitaxel—breast cancer	0.000104	0.000266	CcSEcCtD
Estazolam—Headache—Fluorouracil—breast cancer	0.000104	0.000265	CcSEcCtD
Estazolam—Dyspnoea—Capecitabine—breast cancer	0.000104	0.000264	CcSEcCtD
Estazolam—Flurazepam—CYP3A4—breast cancer	0.000103	0.0229	CrCbGaD
Estazolam—Nausea—Irinotecan—breast cancer	0.000103	0.000263	CcSEcCtD
Estazolam—Nausea—Mitoxantrone—breast cancer	0.000103	0.000263	CcSEcCtD
Estazolam—Triazolam—CYP3A4—breast cancer	0.000103	0.0229	CrCbGaD
Estazolam—Constipation—Docetaxel—breast cancer	0.000103	0.000261	CcSEcCtD
Estazolam—Pain—Docetaxel—breast cancer	0.000103	0.000261	CcSEcCtD
Estazolam—Back pain—Methotrexate—breast cancer	0.000102	0.000261	CcSEcCtD
Estazolam—Dyspepsia—Capecitabine—breast cancer	0.000102	0.000261	CcSEcCtD
Estazolam—Chills—Epirubicin—breast cancer	0.000102	0.00026	CcSEcCtD
Estazolam—Arrhythmia—Epirubicin—breast cancer	0.000102	0.000259	CcSEcCtD
Estazolam—Visual impairment—Doxorubicin—breast cancer	0.000102	0.000259	CcSEcCtD
Estazolam—Asthenia—Paclitaxel—breast cancer	0.000102	0.000259	CcSEcCtD
Estazolam—Decreased appetite—Capecitabine—breast cancer	0.000101	0.000257	CcSEcCtD
Estazolam—Nausea—Gemcitabine—breast cancer	0.0001	0.000256	CcSEcCtD
Estazolam—Pruritus—Paclitaxel—breast cancer	0.0001	0.000255	CcSEcCtD
Estazolam—Oxazepam—CYP3A4—breast cancer	9.99e-05	0.0222	CrCbGaD
Estazolam—Erythema multiforme—Doxorubicin—breast cancer	9.97e-05	0.000254	CcSEcCtD
Estazolam—Pain—Capecitabine—breast cancer	9.93e-05	0.000253	CcSEcCtD
Estazolam—Constipation—Capecitabine—breast cancer	9.93e-05	0.000253	CcSEcCtD
Estazolam—Malnutrition—Epirubicin—breast cancer	9.92e-05	0.000253	CcSEcCtD
Estazolam—Feeling abnormal—Docetaxel—breast cancer	9.89e-05	0.000252	CcSEcCtD
Estazolam—Nausea—Fluorouracil—breast cancer	9.87e-05	0.000252	CcSEcCtD
Estazolam—Temazepam—CYP3A4—breast cancer	9.86e-05	0.0219	CrCbGaD
Estazolam—Ill-defined disorder—Methotrexate—breast cancer	9.83e-05	0.00025	CcSEcCtD
Estazolam—Tinnitus—Doxorubicin—breast cancer	9.83e-05	0.00025	CcSEcCtD
Estazolam—Gastrointestinal pain—Docetaxel—breast cancer	9.81e-05	0.00025	CcSEcCtD
Estazolam—Flushing—Doxorubicin—breast cancer	9.78e-05	0.000249	CcSEcCtD
Estazolam—Flatulence—Epirubicin—breast cancer	9.77e-05	0.000249	CcSEcCtD
Estazolam—Tension—Epirubicin—breast cancer	9.73e-05	0.000248	CcSEcCtD
Estazolam—Nitrazepam—ABCB1—breast cancer	9.66e-05	0.0214	CrCbGaD
Estazolam—Nervousness—Epirubicin—breast cancer	9.63e-05	0.000245	CcSEcCtD
Estazolam—Back pain—Epirubicin—breast cancer	9.59e-05	0.000244	CcSEcCtD
Estazolam—Feeling abnormal—Capecitabine—breast cancer	9.57e-05	0.000244	CcSEcCtD
Estazolam—Midazolam—CYP3A4—breast cancer	9.57e-05	0.0212	CrCbGaD
Estazolam—Malaise—Methotrexate—breast cancer	9.56e-05	0.000243	CcSEcCtD
Estazolam—Muscle spasms—Epirubicin—breast cancer	9.53e-05	0.000243	CcSEcCtD
Estazolam—Gastrointestinal pain—Capecitabine—breast cancer	9.5e-05	0.000242	CcSEcCtD
Estazolam—Body temperature increased—Docetaxel—breast cancer	9.49e-05	0.000242	CcSEcCtD
Estazolam—Abdominal pain—Docetaxel—breast cancer	9.49e-05	0.000242	CcSEcCtD
Estazolam—Leukopenia—Methotrexate—breast cancer	9.49e-05	0.000242	CcSEcCtD
Estazolam—Chills—Doxorubicin—breast cancer	9.46e-05	0.000241	CcSEcCtD
Estazolam—Arrhythmia—Doxorubicin—breast cancer	9.42e-05	0.00024	CcSEcCtD
Estazolam—Dizziness—Paclitaxel—breast cancer	9.36e-05	0.000239	CcSEcCtD
Estazolam—Cough—Methotrexate—breast cancer	9.25e-05	0.000236	CcSEcCtD
Estazolam—Urticaria—Capecitabine—breast cancer	9.23e-05	0.000235	CcSEcCtD
Estazolam—Ill-defined disorder—Epirubicin—breast cancer	9.2e-05	0.000234	CcSEcCtD
Estazolam—Abdominal pain—Capecitabine—breast cancer	9.18e-05	0.000234	CcSEcCtD
Estazolam—Body temperature increased—Capecitabine—breast cancer	9.18e-05	0.000234	CcSEcCtD
Estazolam—Convulsion—Methotrexate—breast cancer	9.18e-05	0.000234	CcSEcCtD
Estazolam—Malnutrition—Doxorubicin—breast cancer	9.18e-05	0.000234	CcSEcCtD
Estazolam—Agitation—Epirubicin—breast cancer	9.11e-05	0.000232	CcSEcCtD
Estazolam—Flatulence—Doxorubicin—breast cancer	9.04e-05	0.00023	CcSEcCtD
Estazolam—Myalgia—Methotrexate—breast cancer	9.02e-05	0.00023	CcSEcCtD
Estazolam—Arthralgia—Methotrexate—breast cancer	9.02e-05	0.00023	CcSEcCtD
Estazolam—Chest pain—Methotrexate—breast cancer	9.02e-05	0.00023	CcSEcCtD
Estazolam—Tension—Doxorubicin—breast cancer	9e-05	0.000229	CcSEcCtD
Estazolam—Vomiting—Paclitaxel—breast cancer	9e-05	0.000229	CcSEcCtD
Estazolam—Malaise—Epirubicin—breast cancer	8.94e-05	0.000228	CcSEcCtD
Estazolam—Rash—Paclitaxel—breast cancer	8.93e-05	0.000227	CcSEcCtD
Estazolam—Dermatitis—Paclitaxel—breast cancer	8.92e-05	0.000227	CcSEcCtD
Estazolam—Discomfort—Methotrexate—breast cancer	8.91e-05	0.000227	CcSEcCtD
Estazolam—Nervousness—Doxorubicin—breast cancer	8.91e-05	0.000227	CcSEcCtD
Estazolam—Syncope—Epirubicin—breast cancer	8.89e-05	0.000227	CcSEcCtD
Estazolam—Leukopenia—Epirubicin—breast cancer	8.88e-05	0.000226	CcSEcCtD
Estazolam—Back pain—Doxorubicin—breast cancer	8.88e-05	0.000226	CcSEcCtD
Estazolam—Headache—Paclitaxel—breast cancer	8.87e-05	0.000226	CcSEcCtD
Estazolam—Hypersensitivity—Docetaxel—breast cancer	8.84e-05	0.000225	CcSEcCtD
Estazolam—Muscle spasms—Doxorubicin—breast cancer	8.82e-05	0.000225	CcSEcCtD
Estazolam—Palpitations—Epirubicin—breast cancer	8.76e-05	0.000223	CcSEcCtD
Estazolam—Confusional state—Methotrexate—breast cancer	8.72e-05	0.000222	CcSEcCtD
Estazolam—Loss of consciousness—Epirubicin—breast cancer	8.72e-05	0.000222	CcSEcCtD
Estazolam—Cough—Epirubicin—breast cancer	8.65e-05	0.00022	CcSEcCtD
Estazolam—Asthenia—Docetaxel—breast cancer	8.61e-05	0.000219	CcSEcCtD
Estazolam—Convulsion—Epirubicin—breast cancer	8.59e-05	0.000219	CcSEcCtD
Estazolam—Flurazepam—ABCB1—breast cancer	8.59e-05	0.0191	CrCbGaD
Estazolam—Hypersensitivity—Capecitabine—breast cancer	8.56e-05	0.000218	CcSEcCtD
Estazolam—Ill-defined disorder—Doxorubicin—breast cancer	8.51e-05	0.000217	CcSEcCtD
Estazolam—Pruritus—Docetaxel—breast cancer	8.49e-05	0.000216	CcSEcCtD
Estazolam—Arthralgia—Epirubicin—breast cancer	8.44e-05	0.000215	CcSEcCtD
Estazolam—Chest pain—Epirubicin—breast cancer	8.44e-05	0.000215	CcSEcCtD
Estazolam—Myalgia—Epirubicin—breast cancer	8.44e-05	0.000215	CcSEcCtD
Estazolam—Agitation—Doxorubicin—breast cancer	8.43e-05	0.000215	CcSEcCtD
Estazolam—Anxiety—Epirubicin—breast cancer	8.41e-05	0.000214	CcSEcCtD
Estazolam—Nausea—Paclitaxel—breast cancer	8.41e-05	0.000214	CcSEcCtD
Estazolam—Hyperhidrosis—Methotrexate—breast cancer	8.36e-05	0.000213	CcSEcCtD
Estazolam—Discomfort—Epirubicin—breast cancer	8.34e-05	0.000213	CcSEcCtD
Estazolam—Asthenia—Capecitabine—breast cancer	8.34e-05	0.000212	CcSEcCtD
Estazolam—Malaise—Doxorubicin—breast cancer	8.27e-05	0.000211	CcSEcCtD
Estazolam—Dry mouth—Epirubicin—breast cancer	8.26e-05	0.00021	CcSEcCtD
Estazolam—Syncope—Doxorubicin—breast cancer	8.23e-05	0.00021	CcSEcCtD
Estazolam—Pruritus—Capecitabine—breast cancer	8.22e-05	0.000209	CcSEcCtD
Estazolam—Leukopenia—Doxorubicin—breast cancer	8.21e-05	0.000209	CcSEcCtD
Estazolam—Diazepam—CYP3A4—breast cancer	8.2e-05	0.0182	CrCbGaD
Estazolam—Confusional state—Epirubicin—breast cancer	8.16e-05	0.000208	CcSEcCtD
Estazolam—Palpitations—Doxorubicin—breast cancer	8.11e-05	0.000207	CcSEcCtD
Estazolam—Oedema—Epirubicin—breast cancer	8.09e-05	0.000206	CcSEcCtD
Estazolam—Loss of consciousness—Doxorubicin—breast cancer	8.06e-05	0.000205	CcSEcCtD
Estazolam—Cough—Doxorubicin—breast cancer	8.01e-05	0.000204	CcSEcCtD
Estazolam—Midazolam—ABCB1—breast cancer	7.96e-05	0.0177	CrCbGaD
Estazolam—Shock—Epirubicin—breast cancer	7.96e-05	0.000203	CcSEcCtD
Estazolam—Convulsion—Doxorubicin—breast cancer	7.95e-05	0.000203	CcSEcCtD
Estazolam—Dizziness—Docetaxel—breast cancer	7.93e-05	0.000202	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Methotrexate—breast cancer	7.88e-05	0.000201	CcSEcCtD
Estazolam—Hyperhidrosis—Epirubicin—breast cancer	7.82e-05	0.000199	CcSEcCtD
Estazolam—Arthralgia—Doxorubicin—breast cancer	7.81e-05	0.000199	CcSEcCtD
Estazolam—Chest pain—Doxorubicin—breast cancer	7.81e-05	0.000199	CcSEcCtD
Estazolam—Myalgia—Doxorubicin—breast cancer	7.81e-05	0.000199	CcSEcCtD
Estazolam—Anxiety—Doxorubicin—breast cancer	7.78e-05	0.000198	CcSEcCtD
Estazolam—Paraesthesia—Methotrexate—breast cancer	7.77e-05	0.000198	CcSEcCtD
Estazolam—Discomfort—Doxorubicin—breast cancer	7.72e-05	0.000197	CcSEcCtD
Estazolam—Dyspnoea—Methotrexate—breast cancer	7.71e-05	0.000196	CcSEcCtD
Estazolam—Somnolence—Methotrexate—breast cancer	7.69e-05	0.000196	CcSEcCtD
Estazolam—Dizziness—Capecitabine—breast cancer	7.68e-05	0.000196	CcSEcCtD
Estazolam—Dry mouth—Doxorubicin—breast cancer	7.64e-05	0.000195	CcSEcCtD
Estazolam—Vomiting—Docetaxel—breast cancer	7.63e-05	0.000194	CcSEcCtD
Estazolam—Dyspepsia—Methotrexate—breast cancer	7.61e-05	0.000194	CcSEcCtD
Estazolam—Rash—Docetaxel—breast cancer	7.57e-05	0.000193	CcSEcCtD
Estazolam—Dermatitis—Docetaxel—breast cancer	7.56e-05	0.000193	CcSEcCtD
Estazolam—Confusional state—Doxorubicin—breast cancer	7.55e-05	0.000192	CcSEcCtD
Estazolam—Decreased appetite—Methotrexate—breast cancer	7.52e-05	0.000192	CcSEcCtD
Estazolam—Headache—Docetaxel—breast cancer	7.52e-05	0.000192	CcSEcCtD
Estazolam—Oedema—Doxorubicin—breast cancer	7.49e-05	0.000191	CcSEcCtD
Estazolam—Pain—Methotrexate—breast cancer	7.4e-05	0.000188	CcSEcCtD
Estazolam—Vomiting—Capecitabine—breast cancer	7.39e-05	0.000188	CcSEcCtD
Estazolam—Musculoskeletal discomfort—Epirubicin—breast cancer	7.37e-05	0.000188	CcSEcCtD
Estazolam—Shock—Doxorubicin—breast cancer	7.37e-05	0.000188	CcSEcCtD
Estazolam—Rash—Capecitabine—breast cancer	7.32e-05	0.000187	CcSEcCtD
Estazolam—Dermatitis—Capecitabine—breast cancer	7.32e-05	0.000186	CcSEcCtD
Estazolam—Headache—Capecitabine—breast cancer	7.28e-05	0.000185	CcSEcCtD
Estazolam—Paraesthesia—Epirubicin—breast cancer	7.27e-05	0.000185	CcSEcCtD
Estazolam—Hyperhidrosis—Doxorubicin—breast cancer	7.24e-05	0.000184	CcSEcCtD
Estazolam—Dyspnoea—Epirubicin—breast cancer	7.22e-05	0.000184	CcSEcCtD
Estazolam—Somnolence—Epirubicin—breast cancer	7.19e-05	0.000183	CcSEcCtD
Estazolam—Diazepam—ALB—breast cancer	7.15e-05	0.0159	CrCbGaD
Estazolam—Nausea—Docetaxel—breast cancer	7.13e-05	0.000182	CcSEcCtD
Estazolam—Feeling abnormal—Methotrexate—breast cancer	7.13e-05	0.000182	CcSEcCtD
Estazolam—Dyspepsia—Epirubicin—breast cancer	7.12e-05	0.000182	CcSEcCtD
Estazolam—Gastrointestinal pain—Methotrexate—breast cancer	7.07e-05	0.00018	CcSEcCtD
Estazolam—Decreased appetite—Epirubicin—breast cancer	7.04e-05	0.000179	CcSEcCtD
Estazolam—Constipation—Epirubicin—breast cancer	6.92e-05	0.000176	CcSEcCtD
Estazolam—Pain—Epirubicin—breast cancer	6.92e-05	0.000176	CcSEcCtD
Estazolam—Nausea—Capecitabine—breast cancer	6.9e-05	0.000176	CcSEcCtD
Estazolam—Urticaria—Methotrexate—breast cancer	6.87e-05	0.000175	CcSEcCtD
Estazolam—Abdominal pain—Methotrexate—breast cancer	6.84e-05	0.000174	CcSEcCtD
Estazolam—Body temperature increased—Methotrexate—breast cancer	6.84e-05	0.000174	CcSEcCtD
Estazolam—Diazepam—ABCB1—breast cancer	6.82e-05	0.0151	CrCbGaD
Estazolam—Musculoskeletal discomfort—Doxorubicin—breast cancer	6.82e-05	0.000174	CcSEcCtD
Estazolam—Paraesthesia—Doxorubicin—breast cancer	6.72e-05	0.000171	CcSEcCtD
Estazolam—Dyspnoea—Doxorubicin—breast cancer	6.68e-05	0.00017	CcSEcCtD
Estazolam—Feeling abnormal—Epirubicin—breast cancer	6.67e-05	0.00017	CcSEcCtD
Estazolam—Somnolence—Doxorubicin—breast cancer	6.66e-05	0.00017	CcSEcCtD
Estazolam—Gastrointestinal pain—Epirubicin—breast cancer	6.62e-05	0.000169	CcSEcCtD
Estazolam—Dyspepsia—Doxorubicin—breast cancer	6.59e-05	0.000168	CcSEcCtD
Estazolam—Decreased appetite—Doxorubicin—breast cancer	6.51e-05	0.000166	CcSEcCtD
Estazolam—Urticaria—Epirubicin—breast cancer	6.43e-05	0.000164	CcSEcCtD
Estazolam—Constipation—Doxorubicin—breast cancer	6.4e-05	0.000163	CcSEcCtD
Estazolam—Pain—Doxorubicin—breast cancer	6.4e-05	0.000163	CcSEcCtD
Estazolam—Abdominal pain—Epirubicin—breast cancer	6.4e-05	0.000163	CcSEcCtD
Estazolam—Body temperature increased—Epirubicin—breast cancer	6.4e-05	0.000163	CcSEcCtD
Estazolam—Hypersensitivity—Methotrexate—breast cancer	6.37e-05	0.000162	CcSEcCtD
Estazolam—Asthenia—Methotrexate—breast cancer	6.2e-05	0.000158	CcSEcCtD
Estazolam—Feeling abnormal—Doxorubicin—breast cancer	6.17e-05	0.000157	CcSEcCtD
Estazolam—Gastrointestinal pain—Doxorubicin—breast cancer	6.12e-05	0.000156	CcSEcCtD
Estazolam—Pruritus—Methotrexate—breast cancer	6.12e-05	0.000156	CcSEcCtD
Estazolam—Hypersensitivity—Epirubicin—breast cancer	5.96e-05	0.000152	CcSEcCtD
Estazolam—Urticaria—Doxorubicin—breast cancer	5.95e-05	0.000152	CcSEcCtD
Estazolam—Abdominal pain—Doxorubicin—breast cancer	5.92e-05	0.000151	CcSEcCtD
Estazolam—Body temperature increased—Doxorubicin—breast cancer	5.92e-05	0.000151	CcSEcCtD
Estazolam—Asthenia—Epirubicin—breast cancer	5.81e-05	0.000148	CcSEcCtD
Estazolam—Pruritus—Epirubicin—breast cancer	5.73e-05	0.000146	CcSEcCtD
Estazolam—Dizziness—Methotrexate—breast cancer	5.72e-05	0.000146	CcSEcCtD
Estazolam—Hypersensitivity—Doxorubicin—breast cancer	5.52e-05	0.000141	CcSEcCtD
Estazolam—Vomiting—Methotrexate—breast cancer	5.5e-05	0.00014	CcSEcCtD
Estazolam—Rash—Methotrexate—breast cancer	5.45e-05	0.000139	CcSEcCtD
Estazolam—Dermatitis—Methotrexate—breast cancer	5.45e-05	0.000139	CcSEcCtD
Estazolam—Headache—Methotrexate—breast cancer	5.42e-05	0.000138	CcSEcCtD
Estazolam—Asthenia—Doxorubicin—breast cancer	5.37e-05	0.000137	CcSEcCtD
Estazolam—Dizziness—Epirubicin—breast cancer	5.35e-05	0.000136	CcSEcCtD
Estazolam—Pruritus—Doxorubicin—breast cancer	5.3e-05	0.000135	CcSEcCtD
Estazolam—Vomiting—Epirubicin—breast cancer	5.15e-05	0.000131	CcSEcCtD
Estazolam—Nausea—Methotrexate—breast cancer	5.14e-05	0.000131	CcSEcCtD
Estazolam—Rash—Epirubicin—breast cancer	5.1e-05	0.00013	CcSEcCtD
Estazolam—Dermatitis—Epirubicin—breast cancer	5.1e-05	0.00013	CcSEcCtD
Estazolam—Headache—Epirubicin—breast cancer	5.07e-05	0.000129	CcSEcCtD
Estazolam—Dizziness—Doxorubicin—breast cancer	4.95e-05	0.000126	CcSEcCtD
Estazolam—Nausea—Epirubicin—breast cancer	4.81e-05	0.000122	CcSEcCtD
Estazolam—Vomiting—Doxorubicin—breast cancer	4.76e-05	0.000121	CcSEcCtD
Estazolam—Rash—Doxorubicin—breast cancer	4.72e-05	0.00012	CcSEcCtD
Estazolam—Dermatitis—Doxorubicin—breast cancer	4.72e-05	0.00012	CcSEcCtD
Estazolam—Headache—Doxorubicin—breast cancer	4.69e-05	0.00012	CcSEcCtD
Estazolam—Nausea—Doxorubicin—breast cancer	4.45e-05	0.000113	CcSEcCtD
Estazolam—GABRG2—Transmission across Chemical Synapses—MDM2—breast cancer	3.27e-05	0.000548	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—BRAF—breast cancer	3.27e-05	0.000548	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—NCOA2—breast cancer	3.26e-05	0.000547	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CXCL8—breast cancer	3.26e-05	0.000546	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—RAF1—breast cancer	3.26e-05	0.000546	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—STAT3—breast cancer	3.25e-05	0.000546	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—MDM2—breast cancer	3.25e-05	0.000545	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—SLC5A5—breast cancer	3.24e-05	0.000544	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—RAF1—breast cancer	3.24e-05	0.000544	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—HMOX1—breast cancer	3.21e-05	0.000538	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—MDM2—breast cancer	3.2e-05	0.000537	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—RAF1—breast cancer	3.19e-05	0.000535	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—SLC2A1—breast cancer	3.19e-05	0.000535	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—SLC5A5—breast cancer	3.19e-05	0.000535	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—BRAF—breast cancer	3.17e-05	0.000532	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—SLC5A5—breast cancer	3.17e-05	0.000531	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—HMOX1—breast cancer	3.16e-05	0.00053	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—SLC2A1—breast cancer	3.13e-05	0.000525	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—IL1B—breast cancer	3.12e-05	0.000524	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—breast cancer	3.12e-05	0.000523	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—BRAF—breast cancer	3.12e-05	0.000523	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—SLC5A5—breast cancer	3.11e-05	0.000522	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—MAPK3—breast cancer	3.11e-05	0.000521	CbGpPWpGaD
Estazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	3.1e-05	0.00052	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—ABCB1—breast cancer	3.08e-05	0.000517	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—SLC2A1—breast cancer	3.08e-05	0.000516	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—BRAF—breast cancer	3.06e-05	0.000514	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—SLC2A1—breast cancer	3.06e-05	0.000513	CbGpPWpGaD
Estazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	3.05e-05	0.000512	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—BRAF—breast cancer	3.04e-05	0.00051	CbGpPWpGaD
Estazolam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	3.04e-05	0.00051	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—ABCB1—breast cancer	3.03e-05	0.000509	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—JUN—breast cancer	3.03e-05	0.000508	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—breast cancer	3.01e-05	0.000504	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—SLC2A1—breast cancer	3e-05	0.000504	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—NCOA1—breast cancer	3e-05	0.000504	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—BRAF—breast cancer	2.99e-05	0.000501	CbGpPWpGaD
Estazolam—GABRR1—Transmission across Chemical Synapses—HRAS—breast cancer	2.96e-05	0.000497	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—TFRC—breast cancer	2.96e-05	0.000496	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—PLG—breast cancer	2.93e-05	0.000491	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—NCOA1—breast cancer	2.92e-05	0.000489	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—NCOA1—breast cancer	2.87e-05	0.000481	CbGpPWpGaD
Estazolam—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	2.86e-05	0.00048	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—MDM2—breast cancer	2.86e-05	0.000479	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—NCOA2—breast cancer	2.85e-05	0.000478	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—RAF1—breast cancer	2.85e-05	0.000477	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—PLG—breast cancer	2.84e-05	0.000477	CbGpPWpGaD
Estazolam—GABRR2—Transmission across Chemical Synapses—HRAS—breast cancer	2.83e-05	0.000474	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—NCOA1—breast cancer	2.82e-05	0.000472	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—MTR—breast cancer	2.81e-05	0.000471	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—NCOA1—breast cancer	2.8e-05	0.000469	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—PLG—breast cancer	2.79e-05	0.000468	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—HPGDS—breast cancer	2.76e-05	0.000462	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—NCOA1—breast cancer	2.75e-05	0.000461	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—PLG—breast cancer	2.74e-05	0.00046	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—MDM2—breast cancer	2.74e-05	0.000459	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—RAF1—breast cancer	2.73e-05	0.000458	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—PLG—breast cancer	2.73e-05	0.000457	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—SLC5A5—breast cancer	2.72e-05	0.000456	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—HMOX1—breast cancer	2.7e-05	0.000453	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—PLG—breast cancer	2.68e-05	0.000449	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTT1—breast cancer	2.67e-05	0.000448	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—MDM2—breast cancer	2.66e-05	0.000446	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—RAF1—breast cancer	2.65e-05	0.000444	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—breast cancer	2.65e-05	0.000444	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—SLC2A1—breast cancer	2.63e-05	0.00044	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—HMOX1—breast cancer	2.62e-05	0.00044	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—BRAF—breast cancer	2.61e-05	0.000438	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—MDM2—breast cancer	2.61e-05	0.000438	CbGpPWpGaD
Estazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	2.61e-05	0.000437	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—RAF1—breast cancer	2.6e-05	0.000436	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—breast cancer	2.59e-05	0.000435	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—HMOX1—breast cancer	2.58e-05	0.000432	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—MDM2—breast cancer	2.57e-05	0.00043	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—RAF1—breast cancer	2.56e-05	0.000429	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—MDM2—breast cancer	2.55e-05	0.000428	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—RAF1—breast cancer	2.54e-05	0.000426	CbGpPWpGaD
Estazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	2.53e-05	0.000425	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—HMOX1—breast cancer	2.53e-05	0.000425	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP17A1—breast cancer	2.53e-05	0.000424	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—breast cancer	2.52e-05	0.000422	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—HMOX1—breast cancer	2.52e-05	0.000422	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—PTGS1—breast cancer	2.51e-05	0.00042	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—MDM2—breast cancer	2.5e-05	0.00042	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	2.5e-05	0.000419	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—RAF1—breast cancer	2.49e-05	0.000418	CbGpPWpGaD
Estazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	2.49e-05	0.000417	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—breast cancer	2.47e-05	0.000415	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—HMOX1—breast cancer	2.47e-05	0.000414	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP2D6—breast cancer	2.46e-05	0.000412	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—ALB—breast cancer	2.45e-05	0.000411	CbGpPWpGaD
Estazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	2.44e-05	0.00041	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—breast cancer	2.43e-05	0.000408	CbGpPWpGaD
Estazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	2.43e-05	0.000407	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	2.42e-05	0.000406	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—breast cancer	2.41e-05	0.000405	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—NCOA2—breast cancer	2.41e-05	0.000404	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—NCOA1—breast cancer	2.4e-05	0.000403	CbGpPWpGaD
Estazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	2.39e-05	0.0004	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—HRAS—breast cancer	2.37e-05	0.000398	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—breast cancer	2.37e-05	0.000398	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—ALB—breast cancer	2.34e-05	0.000392	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—PLG—breast cancer	2.34e-05	0.000392	CbGpPWpGaD
Estazolam—GABRG3—Transmission across Chemical Synapses—HRAS—breast cancer	2.33e-05	0.000391	CbGpPWpGaD
Estazolam—GABRB1—Transmission across Chemical Synapses—HRAS—breast cancer	2.29e-05	0.000385	CbGpPWpGaD
Estazolam—GABRR1—Neuronal System—HRAS—breast cancer	2.27e-05	0.000381	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—TNF—breast cancer	2.27e-05	0.00038	CbGpPWpGaD
Estazolam—GABRR1—Transmembrane transport of small molecules—RAF1—breast cancer	2.22e-05	0.000372	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—MDM2—breast cancer	2.19e-05	0.000367	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—RAF1—breast cancer	2.18e-05	0.000366	CbGpPWpGaD
Estazolam—GABRR2—Neuronal System—HRAS—breast cancer	2.17e-05	0.000363	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—HMOX1—breast cancer	2.16e-05	0.000362	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP1B1—breast cancer	2.13e-05	0.000357	CbGpPWpGaD
Estazolam—GABRR2—Transmembrane transport of small molecules—RAF1—breast cancer	2.12e-05	0.000355	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	2.1e-05	0.000352	CbGpPWpGaD
Estazolam—GABRB3—BDNF signaling pathway—AKT1—breast cancer	2.1e-05	0.000352	CbGpPWpGaD
Estazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	2.08e-05	0.00035	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—breast cancer	2.07e-05	0.000348	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—NCOA1—breast cancer	2.03e-05	0.000341	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP19A1—breast cancer	2e-05	0.000336	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	1.98e-05	0.000331	CbGpPWpGaD
Estazolam—GABRB2—Transmission across Chemical Synapses—HRAS—breast cancer	1.96e-05	0.000329	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—ALB—breast cancer	1.93e-05	0.000323	CbGpPWpGaD
Estazolam—GABRA5—Transmission across Chemical Synapses—HRAS—breast cancer	1.9e-05	0.000319	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—ALB—breast cancer	1.9e-05	0.000318	CbGpPWpGaD
Estazolam—GABRA3—Transmission across Chemical Synapses—HRAS—breast cancer	1.87e-05	0.000314	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—COMT—breast cancer	1.86e-05	0.000312	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTP1—breast cancer	1.85e-05	0.000311	CbGpPWpGaD
Estazolam—GABRA2—Transmission across Chemical Synapses—HRAS—breast cancer	1.84e-05	0.000308	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—COMT—breast cancer	1.84e-05	0.000308	CbGpPWpGaD
Estazolam—GABRA1—SIDS Susceptibility Pathways—IL6—breast cancer	1.83e-05	0.000307	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	1.83e-05	0.000307	CbGpPWpGaD
Estazolam—GABRB3—Transmission across Chemical Synapses—HRAS—breast cancer	1.83e-05	0.000306	CbGpPWpGaD
Estazolam—GABRG2—Transmission across Chemical Synapses—HRAS—breast cancer	1.79e-05	0.000301	CbGpPWpGaD
Estazolam—GABRG3—Neuronal System—HRAS—breast cancer	1.78e-05	0.000299	CbGpPWpGaD
Estazolam—GABRB1—Neuronal System—HRAS—breast cancer	1.76e-05	0.000295	CbGpPWpGaD
Estazolam—GABRG3—Transmembrane transport of small molecules—RAF1—breast cancer	1.74e-05	0.000292	CbGpPWpGaD
Estazolam—GABRB1—Transmembrane transport of small molecules—RAF1—breast cancer	1.72e-05	0.000288	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—GSTM1—breast cancer	1.7e-05	0.000286	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	1.68e-05	0.000282	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—ALB—breast cancer	1.62e-05	0.000272	CbGpPWpGaD
Estazolam—CYP3A4—Biological oxidations—CYP1A1—breast cancer	1.61e-05	0.000271	CbGpPWpGaD
Estazolam—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.59e-05	0.000267	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—ALB—breast cancer	1.58e-05	0.000264	CbGpPWpGaD
Estazolam—GABRA1—Transmission across Chemical Synapses—HRAS—breast cancer	1.57e-05	0.000263	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—ALB—breast cancer	1.55e-05	0.000259	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—ALB—breast cancer	1.52e-05	0.000255	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—ALB—breast cancer	1.51e-05	0.000253	CbGpPWpGaD
Estazolam—GABRB2—Neuronal System—HRAS—breast cancer	1.5e-05	0.000252	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—ALB—breast cancer	1.48e-05	0.000249	CbGpPWpGaD
Estazolam—GABRB2—Transmembrane transport of small molecules—RAF1—breast cancer	1.47e-05	0.000246	CbGpPWpGaD
Estazolam—GABRA5—Neuronal System—HRAS—breast cancer	1.46e-05	0.000245	CbGpPWpGaD
Estazolam—GABRA3—Neuronal System—HRAS—breast cancer	1.43e-05	0.00024	CbGpPWpGaD
Estazolam—GABRA5—Transmembrane transport of small molecules—RAF1—breast cancer	1.42e-05	0.000239	CbGpPWpGaD
Estazolam—GABRA2—Neuronal System—HRAS—breast cancer	1.41e-05	0.000236	CbGpPWpGaD
Estazolam—GABRA3—Transmembrane transport of small molecules—RAF1—breast cancer	1.4e-05	0.000235	CbGpPWpGaD
Estazolam—GABRB3—Neuronal System—HRAS—breast cancer	1.4e-05	0.000235	CbGpPWpGaD
Estazolam—GABRA2—Transmembrane transport of small molecules—RAF1—breast cancer	1.38e-05	0.000231	CbGpPWpGaD
Estazolam—GABRG2—Neuronal System—HRAS—breast cancer	1.37e-05	0.00023	CbGpPWpGaD
Estazolam—GABRB3—Transmembrane transport of small molecules—RAF1—breast cancer	1.37e-05	0.000229	CbGpPWpGaD
Estazolam—GABRG2—Transmembrane transport of small molecules—RAF1—breast cancer	1.34e-05	0.000225	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SYNJ2—breast cancer	1.3e-05	0.000218	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—ALB—breast cancer	1.3e-05	0.000217	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NDUFS3—breast cancer	1.21e-05	0.000202	CbGpPWpGaD
Estazolam—GABRA1—Neuronal System—HRAS—breast cancer	1.2e-05	0.000201	CbGpPWpGaD
Estazolam—GABRA1—Transmembrane transport of small molecules—RAF1—breast cancer	1.17e-05	0.000197	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CHST9—breast cancer	1.14e-05	0.00019	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—COX11—breast cancer	1.08e-05	0.00018	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CDA—breast cancer	9.84e-06	0.000165	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SHMT1—breast cancer	9.84e-06	0.000165	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SLCO1B1—breast cancer	9.47e-06	0.000159	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SLC2A5—breast cancer	9.47e-06	0.000159	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—APRT—breast cancer	9.15e-06	0.000153	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ESRRA—breast cancer	8.6e-06	0.000144	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ANGPTL4—breast cancer	8.6e-06	0.000144	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GPI—breast cancer	8.16e-06	0.000137	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HADHB—breast cancer	8.16e-06	0.000137	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ALDH7A1—breast cancer	7.78e-06	0.00013	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ALDH1A1—breast cancer	7.78e-06	0.00013	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—FHL2—breast cancer	7.46e-06	0.000125	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PHGDH—breast cancer	7.46e-06	0.000125	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ADSL—breast cancer	7.46e-06	0.000125	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—UMPS—breast cancer	7.46e-06	0.000125	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NME1—breast cancer	7.46e-06	0.000125	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HPSE—breast cancer	7.31e-06	0.000123	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—BRIP1—breast cancer	7.31e-06	0.000123	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—LDHB—breast cancer	7.31e-06	0.000123	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HMMR—breast cancer	6.93e-06	0.000116	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ABCC1—breast cancer	6.93e-06	0.000116	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTA3—breast cancer	6.93e-06	0.000116	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PPARGC1B—breast cancer	6.72e-06	0.000113	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CA9—breast cancer	6.34e-06	0.000106	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTA4—breast cancer	6.34e-06	0.000106	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTA2—breast cancer	6.18e-06	0.000104	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GPX2—breast cancer	6.18e-06	0.000104	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SULT1A1—breast cancer	6.1e-06	0.000102	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GPX4—breast cancer	6.1e-06	0.000102	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTA1—breast cancer	5.96e-06	0.0001	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—IDH1—breast cancer	5.96e-06	0.0001	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NAT2—breast cancer	5.9e-06	9.89e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—DPYD—breast cancer	5.17e-06	8.67e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—MED12—breast cancer	5.17e-06	8.67e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ALDOA—breast cancer	5.09e-06	8.54e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NCOA3—breast cancer	4.94e-06	8.29e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SLC2A2—breast cancer	4.91e-06	8.23e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CPT1A—breast cancer	4.81e-06	8.06e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—MTR—breast cancer	4.81e-06	8.06e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ABCG2—breast cancer	4.81e-06	8.06e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HPGDS—breast cancer	4.71e-06	7.91e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HBA1—breast cancer	4.68e-06	7.86e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTT1—breast cancer	4.57e-06	7.67e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ACHE—breast cancer	4.57e-06	7.67e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP17A1—breast cancer	4.33e-06	7.26e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ENO1—breast cancer	4.28e-06	7.19e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PTGS1—breast cancer	4.28e-06	7.19e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP2D6—breast cancer	4.2e-06	7.05e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NCOA2—breast cancer	4.12e-06	6.92e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—FASN—breast cancer	4e-06	6.71e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—BCHE—breast cancer	3.98e-06	6.68e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SLC5A5—breast cancer	3.93e-06	6.6e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—SLC2A1—breast cancer	3.8e-06	6.37e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NQO1—breast cancer	3.8e-06	6.37e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP1B1—breast cancer	3.64e-06	6.11e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.57e-06	5.99e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NCOA1—breast cancer	3.47e-06	5.83e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—STK11—breast cancer	3.42e-06	5.74e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP19A1—breast cancer	3.42e-06	5.74e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—COMT—breast cancer	3.18e-06	5.34e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTP1—breast cancer	3.17e-06	5.31e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—HMOX1—breast cancer	3.13e-06	5.24e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ITPR1—breast cancer	3.12e-06	5.23e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ABCB1—breast cancer	3e-06	5.03e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—TYMS—breast cancer	2.95e-06	4.94e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GSTM1—breast cancer	2.91e-06	4.88e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.91e-06	4.88e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NCOR1—breast cancer	2.91e-06	4.88e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—GPX1—breast cancer	2.79e-06	4.68e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CYP1A1—breast cancer	2.76e-06	4.63e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ERCC2—breast cancer	2.74e-06	4.59e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—MTHFR—breast cancer	2.57e-06	4.32e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—CAV1—breast cancer	2.37e-06	3.98e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CG—breast cancer	2.16e-06	3.63e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CD—breast cancer	1.9e-06	3.19e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—ALB—breast cancer	1.88e-06	3.15e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—NOS3—breast cancer	1.79e-06	3.01e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CB—breast cancer	1.66e-06	2.78e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PTGS2—breast cancer	1.64e-06	2.75e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PTEN—breast cancer	1.43e-06	2.4e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—PIK3CA—breast cancer	1.01e-06	1.69e-05	CbGpPWpGaD
Estazolam—CYP3A4—Metabolism—AKT1—breast cancer	8.25e-07	1.38e-05	CbGpPWpGaD
